Journal
SCIENCE
Volume 322, Issue 5909, Pages 1839-1842Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1165409
Keywords
-
Categories
Funding
- National Heart, Lung, and Blood Institute
- NIH [HL32262-26, HL32259-27]
- Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases
- Howard Hughes Medical Institute
- Leukaemia Research and Kay Kendall Leukaemia Funds
- Medical Scientist Training Program
Ask authors/readers for more resources
Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the beta-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high- HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full- length forms of BCL11A is developmentally restricted to adult erythroid cells. Down- regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the beta- globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in beta- hemoglobin disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available